+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global & Asia Pacific High Throughput Screening Market Outlook 2030

  • ID: 5475210
  • Report
  • October 2021
  • Region: Asia Pacific, Global
  • 203 Pages
  • Research Nester Pvt. Ltd

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • BPS Bioscience Inc.
  • Carna Biosciences Inc.
  • Danaher Corporation
  • Hamilton Company
  • Merck KGaA
High-throughput screening (HTS) is a drug discovery process that is used to analyze chemical and biological compounds. The HTS process involves consumables, instruments, software, and services to identify biological compounds and other biological interactions. The global high-throughput screening (HTS) market is anticipated to grow with a CAGR of 8.4% during the forecast period, i.e., 2021-2030. Factors such as the increasing healthcare expenditure, along with the growing concern for the prevalence of chronic diseases worldwide, and the increasing focus of pharmaceutical and biotechnology companies to develop advanced medicines are expected to contribute to the market growth. The market is estimated to garner a revenue of close to USD 36230 Million by the end of 2030, up from a revenue of around USD 16290 Million in the year 2020.

The global high-throughput screening market is segmented into numerous segments which include segmentation by products & services, technology, application, end-user, and by region. The products & services segment is further divided into consumables, instruments, software, and services, out of which, the consumables segment is projected to grow with the highest CAGR of over 8% during the forecast period. In the year 2020, the segment registered a revenue of about USD 6940 Million, and is further projected to cross USD 15670 Million by the end of 2030.

On the basis of geographical analysis, the global high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in North America is expected to attain the largest revenue of USD 15720 Million approximately by the end of 2030. Amongst the countries in the region, the market in the United States is projected to grow with the highest CAGR of around 9% during the forecast period and also hold the largest market share by the end of 2030.

Some of the prominent industry leaders in the global high-throughput screening (HTS) market that are included in our report are Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Carna Biosciences, Inc., Danaher Corporation, and others.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • BPS Bioscience Inc.
  • Carna Biosciences Inc.
  • Danaher Corporation
  • Hamilton Company
  • Merck KGaA
1. Market Definition and Research Methodology
1.1. Market Definition and Segmentation
1.2. Assumptions and Acronyms
1.3. Research Objective
1.4. Research Methodology

2. Executive Summary

3. Industry Value Chain Analysis

4. Market Dynamics
4.1. Drivers
4.2. Challenges
4.3. Trends
4.4. Opportunities

5. Regulatory & Standards Landscape

6. Industry Risk Analysis

7. Growth Opportunity Analysis for Business Development

8. Impact of COVID-19 on the Global High-Throughput Screening Market

9. Average Pricing Analysis

10. Comparative Analysis

11. Competitive Landscape
11.1. Agilent Technologies, Inc.
11.2. Thermo Fisher Scientific
11.3. Tecan Trading AG
11.4. Promega Corporation
11.5. Hamilton Company
11.6. BPS Bioscience, Inc.
11.7. PerkinElmer Inc.
11.8. Merck KGaA
11.9. Carna Biosciences, Inc.
11.10. Danaher Corporation

12. Global High-Throughput Screening Market
12.1. By Value (USD Million)
12.2. Global High-Throughput Screening Market Segmentation Analysis 2020-2030
12.2.1. By Products & Services
12.2.1.1. Consumables
12.2.1.1.1. Reagents & Assay Kits
12.2.1.1.2. Other Accessories
12.2.1.2. Instruments
12.2.1.2.1. Liquid Handling Systems
12.2.1.2.2. Detection Systems
12.2.1.2.3. Others
12.2.1.3. Software
12.2.1.4. Services
12.2.2. By Technology
12.2.2.1. Cell-Based Assays
12.2.2.1.1. 2D Cell Culture
12.2.2.1.2. 3D Cell Culture
12.2.2.1.2.1. Scaffold-Based Technologies
12.2.2.1.2.1.1. Hydrogel
12.2.2.1.2.1.1.1. Animal Derived Hydrogels
12.2.2.1.2.1.1.1.1. Matrigel
12.2.2.1.2.1.1.1.2. Collagen
12.2.2.1.2.1.1.2. Synthetic Hydrogels
12.2.2.1.2.1.1.3. Alginate/Agarose
12.2.2.1.2.1.2. Inert Matrix
12.2.2.1.2.1.3. Micropatterned Surface
12.2.2.1.2.2. Scaffold-Free Technologies
12.2.2.1.2.2.1. Microplate
12.2.2.1.2.2.2. Hanging-Drop Plates
12.2.2.1.2.2.3. Ultralow Binding Plates
12.2.2.1.2.2.4. Others
12.2.2.1.2.3. Reporter-Based Assays
12.2.2.1.2.4. Perfusion Cell Culture
12.2.2.2. Lab-on-a-Chip Technology
12.2.2.3. Label-Free Technology
12.2.3. By Application
12.2.3.1. Target Identification and Validation
12.2.3.2. Primary and Secondary Screening
12.2.3.3. Toxicology Assessment
12.2.3.4. Others
12.2.4. By End-User
12.2.4.1. Pharmaceuticals and Biotechnology Companies
12.2.4.2. Academic and Government Institutes
12.2.4.3. Contract Research Organization
12.2.4.4. Others
12.2.5. By Region
12.2.5.1. North America
12.2.5.2. Europe
12.2.5.3. Asia-Pacific
12.2.5.4. Latin-America
12.2.5.5. Middle East & Africa
12.3. North America High-Throughput Screening Market
12.3.1. Market by Value (USD Million)
12.3.2. By Products & Services
12.3.2.1. Consumables
12.3.2.1.1. Reagents & Assay Kits
12.3.2.1.2. Other Accessories
12.3.2.2. Instruments
12.3.2.2.1. Liquid Handling Systems
12.3.2.2.2. Detection Systems
12.3.2.2.3. Others
12.3.2.3. Software
12.3.2.4. Services
12.3.3. By Technology
12.3.3.1. Cell-Based Assays
12.3.3.1.1. 2D Cell Culture
12.3.3.1.2. 3D Cell Culture
12.3.3.1.2.1. Scaffold-Based Technologies
12.3.3.1.2.1.1. Hydrogel
12.3.3.1.2.1.1.1. Animal Derived Hydrogels
12.3.3.1.2.1.1.1.1. Matrigel
12.3.3.1.2.1.1.1.2. Collagen
12.3.3.1.2.1.1.2. Synthetic Hydrogels
12.3.3.1.2.1.1.3. Alginate/Agarose
12.3.3.1.2.1.2. Inert Matrix
12.3.3.1.2.1.3. Micropatterned Surface
12.3.3.1.2.2. Scaffold-Free Technologies
12.3.3.1.2.2.1. Microplate
12.3.3.1.2.2.2. Hanging-Drop Plates
12.3.3.1.2.2.3. Ultralow Binding Plates
12.3.3.1.2.2.4. Others
12.3.3.1.2.3. Reporter-Based Assays
12.3.3.1.2.4. Perfusion Cell Culture
12.3.3.2. Lab-on-a-Chip Technology
12.3.3.3. Label-Free Technology
12.3.4. By Application
12.3.4.1. Target Identification and Validation
12.3.4.2. Primary and Secondary Screening
12.3.4.3. Toxicology Assessment
12.3.4.4. Others
12.3.5. By End-User
12.3.5.1. Pharmaceuticals and Biotechnology Companies
12.3.5.2. Academic and Government Institutes
12.3.5.3. Contract Research Organization
12.3.5.4. Others
12.3.6. By Country
12.3.6.1. United States
12.3.6.2. Canada
12.4. Europe High-Throughput Screening Market
12.4.1. Market by Value (USD Million)
12.4.2. By Products & Services
12.4.3. By Technology
12.4.4. By Application
12.4.5. By End-User
12.4.6. By Country
12.4.6.1. UK
12.4.6.2. Germany
12.4.6.3. France
12.4.6.4. Italy
12.4.6.5. Spain
12.4.6.6. Russia
12.4.6.7. Netherlands
12.4.6.8. Rest of Europe
12.5. Asia Pacific High-Throughput Screening Market
12.5.1. Market by Value (USD Million)
12.5.2. By Products & Services
12.5.3. By Technology
12.5.4. By Application
12.5.5. By End-User
12.5.6. By Country
12.5.6.1. China
12.5.6.2. India
12.5.6.3. Japan
12.5.6.4. South Korea
12.5.6.5. Vietnam
12.5.6.6. Singapore
12.5.6.7. Australia
12.5.6.8. Rest of Asia Pacific
12.6. Latin America High-Throughput Screening Market
12.6.1. Market by Value (USD Million)
12.6.2. By Products & Services
12.6.3. By Technology
12.6.4. By Application
12.6.5. By End-User
12.6.6. By Country
12.6.6.1. Brazil
12.6.6.2. Mexico
12.6.6.3. Argentina
12.6.6.4. Rest of Latin America
12.7. Middle East & Africa High-Throughput Screening Market
12.7.1. Market by Value (USD Million)
12.7.2. By Products & Services
12.7.3. By Technology
12.7.4. By Application
12.7.5. By End-User
12.7.6. By Country
12.7.6.1. GCC
12.7.6.2. Israel
12.7.6.3. South Africa
12.7.6.4. Rest of Middle East & Africa
Note: Product cover images may vary from those shown
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific
  • Tecan Trading AG
  • Promega Corporation
  • Hamilton Company
  • BPS Bioscience Inc.
  • PerkinElmer Inc.
  • Merck KGaA
  • Carna Biosciences Inc.
  • Danaher Corporation
Note: Product cover images may vary from those shown